Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000576685 | SCV000677889 | likely pathogenic | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-03-22 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000985385 | SCV001133524 | likely pathogenic | not provided | 2019-07-11 | criteria provided, single submitter | clinical testing | The variant creates a premature nonsense codon, and is therefore predicted to result in the loss of a functional protein. Not found in the total gnomAD dataset, and the data is high quality (0/282034 chr). |
Ambry Genetics | RCV002448809 | SCV002733114 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-07-05 | criteria provided, single submitter | clinical testing | The p.S784* pathogenic mutation (also known as c.2351C>A), located in coding exon 9 of the BRCA1 gene, results from a C to A substitution at nucleotide position 2351. This changes the amino acid from a serine to a stop codon within coding exon 9. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |